Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Lebanon, New Hampshire 03756


Purpose:

The use of Thalidomide in patients with ALS who have disease progression.


Study summary:

Phase II open labeled trial testing the efficacy of thalidomide for ALS in the setting of disease progression.


Criteria:

Inclusion Criteria: - Clinically proven ALS - Disease duration less than or equal to 5 years - ALSFRS-R score equal to or greater then 30 Exclusion Criteria: - Patients with known deep venous thrombosis or hyper coagulable state will be excluded - Patients with FVC less than 80%


NCT ID:

NCT00140452


Primary Contact:

Principal Investigator
Elijah Stommel


Backup Contact:

N/A


Location Contact:

Lebanon, New Hampshire 03756
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 15, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.